Antimicrobial and probiotic properties of yeasts: From fundamental to novel applications

Frontiers in Microbiology

Volumn 3, Issue DEC, 2012, Pages

  Hatoum, Rima ^a   Labrie, Steve ^a   Fliss, Ismail ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Antagonistic activities; Killer toxin; Medical; Mycocin; Probiotic; Veterinary; Yeasts

Indexed keywords

EID: 84875903218     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00421     Document Type: Review

References (189)

1. Adam, J., Barret, A., and Barret-Bellet, C. (1976). Essai clinique controle en double issu de l'ultra levure lyophilisee. Med. Chir. Digest. 5, 401-406.
2. Alexandre, H., Costello, P. J., Remize, F., Guzzo, J., and GuillouxBenatier, M. (2004). Saccharomyces cerevisiae - Oenococcus oeni interactions in wine: current knowledge and perspectives. Int. J. Food Microbiol. 93, 141-154.
3. Almeida, M. J.,and Pais, C. (1996). Leavening ability and freeze tolerance of yeasts isolated from traditional corn and rye bread doughs. Appl. Environ. Microbiol. 62, 4401-4404.
4. Anupama, X., and Ravindra, P. (2000). Value-added food: single cell protein. Biotechnol. Adv. 18, 459-479.
5. Asehraou, A., Peres, C., Brito, D., Faid, M., and Serhrouchni, M. (2007). Characterization of yeast strains isolated from bloaters of fermented green table olives during storage. Grasas Aceites 51, 225-229.
6. Bekatorou, A., Psarianos, C., and Koutinas, A. A. (2006). Production of food grade yeasts. Biopolymers 44, 407-415.
7. Besirbellioglu, B. A., Ulcay, A., Can, M., Erdem, H., Tanyuksel, M., Avci, I. Y., et al. (2006). Saccharomyces boulardii and infection due to Giardia lamblia. Scand. J. Infect. Dis. 38, 479-481.
8. Bevan, E. A., and Somers, J. M. (1969). Somatic segregation of the killer (k) and neutral (n) cytoplasmic genetic determinants in yeast. Genet. Res. 14, 71-77.
9. Bilinski, C. A., and Casey, G. P. (1989). Developments in sporulation and breeding of brewer's yeast. Yeast 5, 429-438.
10. Billoo, A. G., Memon, M. A., Khaskheli, S. A., Murtaza, G., Iqbal, K., Saeed Shekhani, M., et al. (2006). Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J. Gastroenterol. 12, 4557-4560.
11. Bisson, J.-F., Hidalgo, S., Rozan, P., and Messaoudi, M. (2010). Preventive effects of different probiotic formulations on travelers' diarrhea model in wistar rats: preventive effects of probiotics on TD. Dig. Dis. Sci. 55, 911-919.
12. Blanquet, S., Marol-Bonnin, S., Beyssac, E., Pompon, D., Renaud, M., and Alric, M. (2001). The biodrug concept: an innovation approach to therapy. Trends Biotechnol. 19, 393-400.
13. Bleichner, G., Bléhaut, H., Mentec, H., and Moyse, D. (1997). Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. Intensive Care Med. 23, 517-523.
14. Boone, C., Sdicu, A., Degri, R., Sanchez, C., and Bussey, H. (1990). Integration of the yeast "KI" killer toxin in gene into the genome of marked wine yeasts and its effect on vinification. Yeast 41, 37-42.
15. Bortol, A., Nudel, C., Fraile, E., Torres, R., Giulietti, A., Spencer, J. F. T., et al. (1986). Isolation of yeast with killer activity and its breeding with an industrial baking strain by protoplast fusion. Appl. Microbiol. Biotechnol. 24, 414-416.
16. Bradley, G. L., Savage, T. F., and Timm, K. I. (1994). The effects of supplementing diets with Saccharomyces cerevisiae var. boulardii on male poult performance and ileal morphology. Poult. Sci. 73, 1766-1770.
17. Bravo, M.V., Bunout, D., Leiva, L., De La Maza, M. P., Barrera, G., De La Maza, J., et al. (2008). Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment. Rev. Med. Chil. 136, 981-988.
18. Buts, J.-P. (2009). Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Dig. Dis. Sci. 54, 15-18.
19. Buts, J.-P., and Bernasconi, P. (2005). Saccharomyces boulardii: basic science and clinical applications in gastroenterology. Gastroenterol. Clin. North Am. 34, 515-532.
20. Callaway, E. S., and Martin, S. A. (1997). Effects of a Saccharomyces cerevisiae culture on ruminal bacteria that utilize lactate and digest cellulose. J. Dairy Sci. 80, 2035-2044.
21. Can, M., Besirbellioglu, B. A., Avci, I. Y., Beker, C. M., and Pahsa, A. (2006). Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med. Sci. Monit. 12, PI19-PI22.
22. Castagliuolo, I., LaMont, J. T., Nikulasson, S. T., and Pothoulakis, C. (1996). Saccharomyces boulardii protease inhibits Clostridium difficile toxinA effects in the rat ileum. Infect. Immun. 64, 5225-5232.
23. Castagliuolo, I., Riegler, M. F., Valenick, L., LaMont, J. T., and Pothoulakis, C. (1999). Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxinsA and B in human colonic mucosa. Infect. Immun. 67, 302-307.
24. Castex, F., Corthier, G., Jouvert, S., Elmer, G. W., Lucas, F., and Bastide, M. (1990). Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: a scanning electron microscopic and microbiological study. J. Gen. Microbiol. 136, 1085-1089.
25. Cavalero, D. A., and Cooper, D. G. (2003). The effect of medium composition on the structure and physical state of sophorolipids produced by Candida bombicola ATCC 22214. J. Biotechnol. 103, 31-41.
26. Chaffin, W. L., López-Ribot, J. L., Casanova, M., Gozalbo, D., and Martínez, J. P. (1998). Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62, 130-180.
27. Chen, L.-S., Ma, Y., Maubois, J.-L., He, S.-H., Chen, L.-J., and Li, H.-M. (2010). Screening for the potential probiotic yeast strains from raw milk to assimilate cholesterol. Dairy Sci. Technol. 90, 537-548.
28. Chen, W.-B., Han, Y.-F., Jong, S.-C., and Chang, S.-C. (2000). Isolation, purification, and characterization of a killer protein from Schwanniomyces occidentalis. Appl. Environ. Microbiol. 66, 1029-1035.
29. Chiquette, J. (2009). Evaluation of the protective effect of probiotics fed to dairy cows during a subacute ruminal acidosis challenge. Anim. Feed Sci. Technol. 153, 278-291.
30. Ciani, M., and Fatichenti, F. (2001). Killer toxin of Kluyveromyces phaffii DBVPG 6076 as a biopreservative agent to control apiculate wine yeasts. Appl. Environ. Microbiol. 67, 3058-3063.
31. Cindoruk, M., Erkan, G., Karakan, T., Dursun, A., and Unal, S. (2007). Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebocontrolled double-blind study. Helicobacter 12, 309-316.
32. Comitini, F., De Ingeniis, J., Pepe, L., Mannazzu, I., and Ciani, M. (2004a). Pichia anomala and Kluyveromyces wickerhamii killer toxins as new tools against Dekkera/Brettanomyces spoilage yeasts. FEMS Microbiol. Lett. 238, 235-240.
33. Comitini, F., Di Pietro, N., Zacchi, L., Mannazzu, I.,and Ciani, M. (2004b). Kluyveromyces phaffii killer toxin active against wine spoilage yeasts: purification and characterization. Microbiology 150, 2535-2541.
34. Conti, S., Magliani, W., Arseni, S., Frazzi, R., Salati, A., Ravanetti, L., et al. (2002). Inhibition by yeast killer toxin-like antibodies of oral Streptococci adhesion to tooth surfaces in an ex vivo model. Mol. Med. 8, 313-317.
35. Coté, G. A., and Buchman, A. L. (2006). Antibiotic-associated diarrhoea. Expert Opin. Drug. Saf. 5, 361-372.
36. Cremonini, F., Di Caro, S., Covino, M., Armuzzi, A., Gabrielli, M., Santarelli, L., et al. (2002). Effect of different probiotic preparations on antiHelicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am. J. Gastroenterol. 97, 2744-2749.
37. Czerucka, D., Piche, T., and Rampal, P. (2007). Review article: yeast as probiotics - Saccharomyces boulardii. Aliment. Pharmacol. Ther. 26, 767-778.
38. Czerucka, D., and Rampal, P. (2002). Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect. 4, 733-739.
39. Dalmasso, G., Cottrez, F., Imbert, V., Lagadec, P., Peyron, J.-F., Rampal, P., et al. (2006a). Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology 131, 1812-1825.
40. Dalmasso, G., Loubat, A., Dahan, S., Calle, G., Rampal, P., and Czerucka, D. (2006b). Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells. Res. Microbiol. 157, 456-465.
41. Dawes, E. A. (1986). Microbial energetics. Biochem. Educ. 95, 187.
42. Dawson, K. A., Newman, K. E., and Boling, J. A. (1990). Effects of microbial supplements containing yeast and lactobacilli on roughage-fed ruminal microbial activities. J. Anim. Sci. 68, 3392-3398.
43. Deak, T. (2006)."Environmental factors influencing yeasts," in Biodiversity and Ecophysiology ofYeasts (TheYeast Handbook series),eds G. Péter and C. Rosa (Berlin: Springer), 155-174.
44. DeMeo, M., Kolli, S., Keshavarzian, A., Borton, M., Al-Hosni, M., Dyavanapalli, M., et al. (1998). Beneficial effect of a bile acid resin binder on enteral feeding induced diarrhea. Am. J. Gastroenterol. 93, 967-971.
45. Dickinson, J., and Kruckeberg, A. (2006)."Carbohydrate metabolism," in Yeasts in Food and Beverages, eds A. Querol and G. Fleet (Berlin: Springer), 215-242.
46. Dieuleveux, V., Van Der Pyl, D., Chataud, J., and Gueguen, M. (1998). Purification and characterization of anti-Listeria compounds produced by Geotrichum candidum. Appl. Environ. Microbiol. 64, 800-803.
47. D'Souza, A. L., Rajkumar, C., Cooke, J., and Bulpitt, C. J. (2002). Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324, 1361.
48. Duman, D. G., Bor, S., Ozütemiz, O., Sahin, T., Oguz, D., Istan, F., et al. (2005). Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication. Eur. J. Gastroenterol. Hepatol. 17, 1357-1361.
49. Edens, F. W. (2003). An alternative for antibiotic se in poultry: probiotics. Rev. Bras. Cienc. Avic. 5, 75-97.
50. Elmer, G. W., and Corthier, G. (1991). Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii used as a preventative agent in gnotobiotic mice. Can. J. Microbiol. 37, 315-317.
51. Elmer, G. W., and McFarland, L. V. (1987). Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters. Antimicrob. Agents Chemother. 31, 129-131.
52. Elmer, G. W., McFarland, L. V., Surawicz, C. M., Danko, L., and Greenberg, R. N. (1999). Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment. Pharmacol. Ther. 13, 1663-1668.
53. El-neshawy, S. M., and Wilson, C. L. (1997). Nisin enhancement of biocontrol of postharvest diseases of apple with Candida oleophila. Postharvest Biol. Technol. 10, 9-14.
54. Erdeve, O., Tiras, U., and Dallar, Y. (2004). The probiotic effect of Saccharomyces boulardii in a pediatric age group. J. Trop. Pediatr. 50, 234-238.
55. Etienne-Mesmin, L., Livrelli, V., Privat, M., Denis, S., Cardot, J.-M., Alric, M., et al. (2011). Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model. Appl. Environ. Microbiol. 77, 1127-1131.
56. Fatichenti, F., Bergere, J. L., Deiana, P., and Farris, G. A. (1983). Antagonistic activity of Debaryomyces hansenii towards Clostridium tyrobutyricum and C. butyricum. J. Dairy Res. 50, 449-457.
57. Fleet, G. H. (2007). Yeasts in foods and beverages: impact on product quality and safety. Curr. Opin. Biotechnol. 18, 170-175.
58. Foligné, B., Dewulf, J., Vandekerckove, P., Pignède, G., and Pot, B. (2010). Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice. World J. Gastroenterol. 16, 2134-2145.
59. Fonty, G., and Chaucheyras-Durand, F. (2006). Effects and modes of action of live yeasts in the rumen. Biologia 61, 741-750.
60. Fredlund, E., Blank, L. M., Schnürer, J., Sauer, U., and Passoth, V. (2004). Oxygenand glucose-dependent regulation of central carbon metabolism in Pichia anomala. Appl. Environ. Microbiol. 70, 5905-5911.
61. Gao, J., Zhang, H. J., Yu, S. H., Wu, S. G., Yoon, I., Quigley, J., et al. (2008). Effects of yeast culture in broiler diets on performance and immunomodulatory functions. Poult. Sci. 87, 1377-1384.
62. Ghoneum, M., Wang, L., Agrawal, S., and Gollapudi, S. (2007). Yeast therapy for the treatment of breast cancer: a nude mice model study. In vivo 21, 251-258.
63. Gobbetti, M., Corsetti, A., and Rossi, J. (1994). The sourdough microflora. Interactions between lactic acid bacteria and yeasts: metabolism of carbohydrates. Appl. Microbiol. Biotechnol. 41, 456-460.
64. Goerges, S., Aigner, U., Silakowski, B., and Scherer, S. (2006). Inhibition of Listeria monocytogenes by foodborne yeasts. Appl. Environ. Microbiol. 72, 313-318.
65. Goerges, S., Koslowsky, M., Velagic, S., Borst, N., Bockelmann, W., Heller, K. J., et al. (2011). Anti-listerial potential of food-borne yeasts in red smear cheese. Int. Dairy J. 21, 83-89.
66. Goldman, E. (2008). Practical Handbook of Microbiology, 2nd Edn, eds. E. Goldman and L. Green (CRC Press). Available at: http://www.crcnetbase.com/doi/ book/10.1201/9781420009330.
67. Golowczyc, M. A., Mobili, P., Garrote, G. L., de los Angeles Serradell, M., Abraham, A. G., and De Antoni, G. L. (2009). Interaction between Lactobacillus kefir and Saccharomyces lipolytica isolated from kefir grains: evidence for lectin-like activity of bacterial surface proteins. J. Dairy Res. 76, 111-116.
68. Golubev, W. I. (2006). "Antagonistic interactions among yeasts," in Biodiversity and Ecophysiology of Yeasts, eds. G. Péter and C. Rosa (Berlin: Springer), 197-219.
69. Gunge, N., Tamaru, A., Ozawa, F., and Sakaguchi, K. (1981). Isolation and characterization of linear deoxyribonucleic acid plasmids from Kluyveromyces lactis and the plasmidassociated killer character. Yeast 145, 382-390.
70. Guslandi, M., Giollo, P., and Testoni, P. A. (2003). A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 15, 697-698.
71. Guslandi, M., Mezzi, G., Sorghi, M., and Testoni, P. A. (2000). Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig. Dis. Sci. 45, 1462-1464.
72. Halász, A., and Lásztity, R. (1991). Use of Yeast Biomass in Food Production. CRC Press, 352. Available at: http://books.google.ca/books?id= xbZRt2pKwqUC
73. Hara, S., Iimura, Y., and Otsuka, K. (1980). Breeding of useful killer wine yeasts. Am. J. Enol. Vitic. 31, 28-33.
74. Hatoum, R., Labrie, S., and Fliss, I. (2012). Identification and partial characterization of antilisterial compounds produced by dairy yeasts. Probiotics Antimicrob. Proteins 1-10. doi: 10.1007/s12602-012-9109-8
75. Hayduck, F. (1909). Uber einen Hefengiftstoff in Hefe. Wochenschr. Brau. 26, 677-679.
76. Hayman, G. T., and Bolen, P. L. (1991). Linear DNA plasmids of Pichia inositovora are associated with a novel killer toxin activity. Curr. Genet. 19, 389-393.
77. Hernández, A., Martín, A., Córdoba, M. G., Benito, M. J., Aranda, E., and Pérez-Nevado, F. (2008). Determination of killer activity in yeasts isolated from the elaboration of seasoned green table olives. Int. J. Food Microbiol. 121, 178-188.
78. Hibbett, D. S., Binder, M., Bischoff, J. F., Blackwell, M., Cannon, P. F., Eriksson, O. E., et al. (2007). A higherlevel phylogenetic classification of the Fungi. Mycol. Res. 111, 509-547.
79. Hodgson, V. J., Button, D., and Walker, G. M. (1995). Anti-candida activity of a novel killer toxin from the yeast Williopsis mrakii. Microbiology 141, 2003-2012.
80. Holck, P., Sletmoen, M., Stokke, B. T., Permin, H., and Norn, S. (2007). Potentiation of histamine release by Microfungal (1→3)and (1→6)beta-d-glucans. Basic Clin. Pharmacol. Toxicol. 101, 455-458.
81. Hooge, D. M. (2004). Meta-analysis of broiler chicken pen trials evaluating dietary mannan oligosaccharide, 1993-2003. Int. J. Poult. Sci. 3, 163-174.
82. Htwe, K., Yee, K. S., Tin, M., and Vandenplas, Y. (2008). Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in myanmar children: a randomized controlled study. Am. J. Trop. Med. Hyg. 78, 214-216.
83. Ibeas, J. I., Lozano, I., Perdigones, L., and Jimenez, J. (1996). Detection of Dekkera/Brettanomyces strains in sherry by a nested PCR method. Appl. Environ. Microbiol. 62, 998-1003.
84. Izgu, F., and Altinbay, D. (2004). Isolation and characterization of the K5-type yeast killer protein and its homology with an exobeta-1,3-glucanase. Biosci. Biotechnol. Biochem. 68, 685-693.
85. Izgu, F., Altinbay, D., and Acun, T. (2006). Killer toxin of Pichia anomala NCYC 432; purification, characterization and its exo-beta-1,3glucanase activity. Enzyme Microb. Technol. 39, 669-676.
86. Jakobsen, M., and Narvhus, J. (1996). Yeasts and their possible beneficial and negative effects on the quality of dairy products. Int. Dairy J. 6, 755-768.
87. Kagan, B. L. (1983). Mode of action of yeast killer toxins: channel formation in lipid bilayer membranes. Nature 302, 709-711.
88. Karen, M., Yuksel, O., Akyürek, N., Ofluoglu, E., Caglar, K., Sahin, T. T., et al. (2010). Probiotic agent Saccharomyces boulardii reduces the incidence of lung injury in acute necrotizing pancreatitis induced rats. J. Surg. Res. 160, 139-144.
89. Katakura, Y., Sano, R., Hashimoto, T., Ninomiya, K., and Shioya, S. (2010). Lactic acid bacteria display on the cell surface cytosolic proteins that recognize yeast mannan. Appl. Microbiol. Biotechnol. 86, 319-326.
90. Kawarai, T., Furukawa, S., Ogihara, H., and Yamasaki, M. (2007). Mixedspecies biofilm formation by lactic acid bacteria and rice wine yeasts. Appl. Environ. Microbiol. 73, 4673-4676.
91. Kelly, C. P., Pothoulakis, C., and LaMont, J. T. (1994). Current concepts: Clostridium difficile colitis. N. Engl. J. Med. 330, 257-262.
92. Kimura, T., Kitamoto, N., Matsuoka, K., Nakamura, K., Iimura, Y., and Kito, Y. (1993). Isolation and nucleotide sequences of the genes encoding killer toxins from Hansenula mrakii and H. saturnus. Gene 137, 265-270.
93. Kitamoto, H. K., Hasebe, A., Ohmomo, S., Suto, E. G., Muraki, M., and Iimura, Y. (1999). Prevention of aerobic spoilage of maize silage by a genetically modified killer yeast, Kluyveromyces lactis, defective in the ability to grow on lactic acid. Appl. Environ. Microbiol. 65, 4697-4700.
94. Klein, R. D., and Favreau, M. A. (1995). "The Candida species: biochemistry, molecular biology, and industrial applications,"in Food Biothechnology Microorganisms,edsY. H. Hui and G. G. Khachatourians (New York: VCH publishers), 297-371.
95. Kollaritsch, H., Holst, H., Grobara, P., and Wiedermann, G. (1993). Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled doubleblind study. Fortschr. Med. 111, 153-156.
96. Kono, I., and Himeno, K. (1997). A novel killer yeast effective on Schizosaccharomyces pombe. Biosci. Biotechnol. Biochem. 61, 563-564.
97. Kotowska, M., Albrecht, P., and Szajewska, H. (2005). Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized doubleblind placebo-controlled trial. Aliment. Pharmacol. Ther. 21, 583-590.
98. Krämer, S., and Bischoff, S. C. (2006). Therapeutic possibilities of probiotics in antibiotic-related diarrhea. MMW Fortschr. Med. 148, 28-30.
99. Kumura, H., Tanoue, Y., Tsukahara, M., Tanaka, T.,and Shimazaki, K. (2004). Screening of dairy yeast strains for probiotic applications. J. Dairy Sci. 87, 4050-4056.
100. Kurtzman, C. P., Fell, J. W., and Boekhout, T. (2011a). "Definition, classification and nomenclature of the yeasts," in The Yeasts a Taxonomic Study 5th Edn, eds C. P. Kurtzman, J. W. Fell, and T. Boekhout (Amsterdam: Elsevier Science), 3-9.
101. Kurtzman, C. P., Fell, J. W., and Boekhout, T. (2011b). The Yeasts: A Taxonomic Study. Elsevier. Available at: http://books.google.ca/books? id=yfg79rlIFIkC
102. Kurugöl, Z., and Koturoglu, G. (2005). Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr. 94, 44-47.
103. Lammerding, A. M., Garcia, M. M., Mann, E. D., Robinson, Y., Dorward, W. J., Truscott, R. B., et al. (1988). Prevalence of Salmonella and thermophilic Campylobacter in fresh pork, beef, veal and poultry in Canada. J. Food Prot. 51, 47-52.
104. Lewis, S. J., Potts, L. F., and Barry, R. E. (1998). The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibioticrelated diarrhoea in elderly patients. J. Infect. 36, 171-174.
105. Li, J., Li, D., Gong, L., Ma, Y., He, Y., and Zhai, H. (2006). Effects of live yeast on the performance, nutrient digestibility, gastrointestinal microbiota and concentration of volatile fatty acids in weanling pigs. Arch. Anim. Nutr. 60, 277-288.
106. Line, J. E., Bailey, J. S., Cox, N. A., Stern, N. J.,and Tompkins, T. (1998). Effect of yeast-supplemented feed on SalmonellaandCampylobacterpopulations in broilers. Poult. Sci. 77, 405-410.
107. Liu, S., and Tsao, M. (2010a). Biocontrol of spoilage yeasts and moulds by Williopsis saturnus var. saturnus in yoghurt. Nutr. Food Sci. 40, 166-175.
108. Liu, S.-Q., and Tsao, M. (2010b). Enhancing stability of lactic acid bacteria and probiotics by Williopsis saturnus var. saturnus in fermented milks. Nutr. Food Sci. 40, 314-322.
109. Liu, S.-Q., and Tsao, M. (2009a). Biocontrol of dairy moulds by antagonistic dairy yeast Debaryomyces hansenii in yoghurt and cheese at elevated temperatures. Food Control 20, 852-855.
110. Liu, S.-Q., and Tsao, M. (2009b). Enhancement of survival of probiotic and non-probiotic lactic acid bacteria by yeasts in fermented milk under non-refrigerated conditions. Int. J. Food Microbiol. 135, 34-38.
111. Liu, S.-Q., and Tsao, M. (2009c). Inhibition of spoilage yeasts in cheese by killer yeast Williopsis saturnus var. saturnus. Int. J. Food Microbiol. 131, 280-282.
112. Llorente, P., Marquina, D., Santos, A., Peinado, J. M., and Spencer-Martins, I. (1997). Effect of salt on the killer phenotype of yeasts from olive brines. Appl. Environ. Microbiol. 63, 1165-1167.
113. Lowes, K. F., Shearman, C. A., Payne, J., MacKenzie, D., Archer, D. B., Merry, R. J., et al. (2000). Prevention of yeast spoilage in feed and food by the yeast mycocin HMK. Appl. Environ. Microbiol. 66, 1066-1076.
114. Lyons, T. P., Jacques, K. A., and Dawson, K. A. (1993). "Miscellaneous products from yeasts," in The Yeasts, 2nd Edn, Vol. 5, eds A. H. Rose and J. S. Harrison (London: Academic), 293-325.
115. Magliani, W., Conti, S., Frazzi, R., Ravanetti, L., Maffei, D. L., and Polonelli, L. (2005). Protective antifungal yeast killer toxin-like antibodies. Curr. Mol. Med. 5, 443-452.
116. Magliani, W., Conti, S., Gerloni, M., Bertolotti, D., and Polonelli, L. (1997). Yeast killer systems. Clin. Microbiol. Rev. 10, 369-400.
117. Magliani, W., Conti, S., Travassos, L. R., and Polonelli, L. (2008). From yeast killer toxins to antibiobodies and beyond. FEMS Microbiol. Lett. 288, 1-8.
118. Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., and Shafaghi, A. (2003). Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World J. Gastroenterol. 9, 1832-1833.
119. Marquina, D., Peres, C., Caldas, F. V., Marques, J. F., Peinado, J. M., and Spencer-Martins, I. (1992). Characterization of the yeast population in olive brines. Lett. Appl. Microbiol. 14, 279-283.
120. Marquina, D., Santos, A., and Peinado, J. M. (2002). Biology of killer yeasts. Int. Microbiol. 5, 65-71.
121. Masih, E. I., and Paul, B. (2002). Secretion of beta-1,3-glucanases by the yeast Pichia membranifaciens and its possible role in the biocontrol of Botrytis cinerea causing grey mold disease of the grapevine. Curr. Microbiol. 44, 391-395.
122. Masih, E. I., Slezack-Deschaumes, S., Marmaras, I., Barka, E. A., Vernet, G., Charpentier, C., et al. (2001). Characterisation of the yeast Pichia membranifaciens and its possible use in the biological control of Botrytis cinerea, causing the grey mould disease of grapevine. FEMS Microbiol. Lett. 202, 227-232.
123. McFarland, L. V. (2007). Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med. Infect. Dis. 5, 97-105.
124. McFarland, L. V. (2010). Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol. 16, 2202-2222.
125. McFarland, L. V., Elmer, G. W., and McFarland, M. (2006). Metaanalysis of probiotics for the prevention and treatment of acute pediatric diarrhea. Int. J. Probiotics Prebiotics 1, 63-76.
126. Mcfarland, L. V., Surawicz, C. M., Greenberg, R. N., Fekety, R., Elmer, G. W., Moyer, K. A., et al. (1994). A randomized placebo-controlled trial combination with standard antibiotics for Clostridium difficile disease. J. Am. Med. Assoc. 271, 1913-1918.
127. Michalcáková, S., Sulo, P., and Sláviková, E. (1993). Killer yeasts of Kluyveromyces and Hansenula genera with potential application in fermentation and therapy. Acta Biotechnol. 13, 341-350.
128. Millsap, K. W., Van Der Mei, H. C., Bos, R., and Busscher, H. J. (1998). Adhesive interactions between medically important yeasts and bacteria. FEMS Microbiol. Rev. 21, 321-336.
129. Morales-López, R., Auclair, E., Van Immerseel, F., Ducatelle, R., García, F., and Brufau, J. (2010). Effects of different yeast cell wall supplements added to maizeor wheat-based diets for broiler chickens. Br. Poult. Sci. 51, 399-408.
130. Narvhus, J.A.,and Gadaga, T. H. (2003). The role of interaction between yeasts and lactic acid bacteria in African fermented milks: a review. Int. J. Food Microbiol. 86, 51-60.
131. Palpacelli, V., Ciani, M., and Rosini, G. (1991). Activity of different "killer" yeasts on strains of yeast species undesirable in the food industry. FEMS Microbiol. Lett. 68, 75-78.
132. Patterson, J. A., and Burkholder, K. M. (2003). Application of prebiotics and probiotics in poultry production. Poult. Sci. 82, 627-631.
133. Pfeiffer, P., and Radler, F. (1984). Comparison of the killer toxin of several yeasts and the purification of a toxin of type K2. Arch. Microbiol. 137, 357-361.
134. Plein, K.,and Hotz, J. (1993). Therapeutic effects of Saccharomyces boulardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhea - a pilot study. Z. Gastroenterol. 31, 129-134.
135. Polonelli, L., Lorenzini, R., De Bernardis, F., and Morace, G. (1986). Potential therapeutic effect of yeast killer toxin. Mycopathologia 96, 103-107.
136. Polonelli, L., Magliani, W., Ciociola, T., Giovati, L., and Conti, S. (2011). From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy. Antonie Van Leeuwenhoek 99, 35-41.
137. Pothoulakis, C. (2009). Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment. Pharmacol. Ther. 30, 826-833.
138. Pothoulakis, C., Kelly, C. P., Joshi, M. A., Gao, N., O'Keane, C. J., Castagliuolo, I., et al. (1993). Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 104, 1108-1115.
139. Pretorius, I. S. (2000). Tailoring wine yeast for the new millennium: novel approaches to the ancient art of winemaking. Yeast 16, 675-729.
140. Pretorius, I. S., du Toit, M., and van Rensburg, P. (2003). Designer yeasts for the fermentation industry of the 21st century. Food Technol. Biotechnol. 41, 3-10.
141. Psani, M., and Kotzekidou, P. (2006). Technological characteristics of yeast strains and their potential as starter adjuncts in Greekstyle black olive fermentation. World J. Microbiol. Biotechnol. 22, 1329-1336.
142. Qamar, A., Aboudola, S., Warny, M., Michetti, P., Pothoulakis, C., LaMont, J. T., et al. (2001). Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect. Immun. 69, 2762-2765.
143. Rigothier, M. C., Maccario, J., and Gayral, P. (1994). Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitol. Res. 80, 10-15.
144. Rodrigues, F., Ludovico, P., and Leão, C. (2006)."Sugar metabolism in yeasts: an overview of aerobic and anaerobic glucose catabolism," in The Yeast Handbook, eds. G. Péter and C. Rosa (Berlin: Springer), 101-121.
145. Romano, P., Capece, A., and Jespersen, L. (2006). "Taxonomic and ecological diversity of food and beverage yeasts," in The Yeast Handbook, eds. A. Querol and G. Fleet (Berlin: Springer), 13-53.
146. Rosini, G., and Cantini, M. (1987). Killer character in Kluyveromyces yeasts: activity on Kloeckera apiculata. FEMS Microbiol. Lett. 44, 81-84.
147. Saint-Marc, T., Blehaut, H., Musial, C., and Touraine, T. (1995).Aids-related diarrhea: a double-blind trial of Saccharomyces boulardii. Sem. Hôsp. Paris 71, 735-741.
148. Santos, A., and Marquina, D. (2004). Ion channel activity by Pichia membranifaciens killer toxin. Yeast 21, 151-162.
149. Sauerwein, H., Schmitz, S., and Hiss, S. (2007). Effects of a dietary application of a yeast cell wall extract on innate and acquired immunity, on oxidative status and growth performance in weanling piglets and on the ileal epithelium in fattened pigs. J. Anim. Physiol. Anim. Nutr. (Berl.) 91, 369-380.
150. Sazawal, S., Hiremath, G., Dhingra, U., Malik, P., Deb, S., and Black, R. E. (2006). Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 6, 374-382.
151. Schmitt, M. J., and Breinig, F. (2002). The viral killer system in yeast: from molecular biology to application. FEMS Microbiol. Rev. 26, 257-276.
152. Séguy, N., Polonelli, L., Dei-Cas, E., and Cailliez, J. C. (1998). Effect of a killer toxin of Pichia anomala to Pneumocystis. Perspectives in the control of pneumocystosis. FEMS Immunol. Med. Microbiol. 22, 145-149.
153. Seki, T., Choi, E.-H., and Ryu, D. (1985). Construction of killer wine yeast strain. Appl. Environ. Microbiol. 49, 1211-1215.
154. Sezer, A., Usta, U., and Cicin, I. (2009). The effect of Saccharomyces boulardii on reducing irinotecaninduced intestinal mucositis and diarrhea. Med. Oncol. 26, 350-357.
155. Spadaro, D., and Gullino, M. L. (2004). State of the art and future prospects of the biological control of postharvest fruit diseases. Int. J. Food Microbiol. 91, 185-194.
156. Suharja, A. A. S., Henriksson, A., and Liu, S.-Q. (2012). Impact of Saccharomyces cerevisiae on viability of probiotic Lactobacillus rhamnosus in fermented milk under ambient conditions. J. Food Process. Preserv. doi:10.1111/j.17454549.2012.00780.x
157. Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., and Van Belle, G. (1990). Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Z. Gastroenterol. 28, 259-260.
158. Surawicz, C. M., McFarland, L. V., Greenberg, R. N., Rubin, M., Fekety, R., Mulligan, M. E., et al. (2000). The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Oxford University Press. Available at: http://www.ncbi. nlm.nih.gov/pubmed/11049785.
159. Suzuki, C., Ando, Y., and Machida, S. (2001). Interaction of SMKT, a killer toxin produced by Pichia farinosa, with the yeast cell membranes. Yeast 8, 1471-1478.
160. Suzuki, C., and Shimma, Y. I. (1999). P-type ATPase spf1 mutants show a novel resistance mechanism for the killer toxin SMKT. Mol. Microbiol. 32, 813-823.
161. Swanson, K. S., Grieshop, C. M., Flickinger, E. A., Bauer, L. L., Healy, H.-P., Dawson, K. A., et al. (2002a). Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. J. Nutr. 132, 980-989.
162. Swanson, K. S., Grieshop, C. M., Flickinger, E. A., Healy, H. P., Dawson, K. A., Merchen, N. R., et al. (2002b). Effects of supplemental fructooligosaccharides plus mannanoligosaccharides on immune function and ileal and fecal microbial populations in adult dogs. Arch. Tierernahr. 56, 309-318.
163. Tanyuksel, M., and Petri, W. A. (2003). Laboratory diagnosis of amebiasis. Society 16, 713-729.
164. Tasteyre, A., Barc, M.-C., Karjalainen, T., Bourlioux, P., and Collignon, A. (2002). Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii. Microb. Pathog. 32, 219-225.
165. Tempé, J. D., Steidel, A. L., Blehaut, H., Hasselmann, M., Lutun, P., and Maurier, F. (1983). Prevention of diarrhea administering Saccharomyces boulardii during continuous enteral feeding. Sem. Hop. 59, 1409-1412.
166. Todd, B. E. N., Fleet, G. H., and Henschke, P. A. (2000). Promotion of autolysis through the interaction of killer and sensitive yeasts: potential application in sparkling wine production. Am. J. Enol. Vitic. 51, 65-72.
167. Valdés-Stauber, N., Scherer, S., and Seiler, H. (1997). Identification of yeasts and coryneform bacteria from the surface microflora of brick cheeses. Int. J. Food Microbiol. 34, 115-129.
168. Van Der Aa Kühle, A., and Jespersen, L. (2003). The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochromec oxidase II gene. Syst. Appl. Microbiol. 26, 564-571.
169. Van DerAa Kühle, A., Skovgaard, K.,and Jespersen, L. (2005). In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int. J. Food Microbiol. 101, 29-39.
170. Van Dijken, J. P., and Scheffers, W. A. (1986). Redox balances in the metabolism of sugars by yeasts. FEMS Microbiol. Lett. 32, 199-224.
171. van Heugten, E., Funderburke, D. W., and Dorton, K. L. (2003). Growth performance, nutrient digestibility, and fecal microflora in weanling pigs fed live yeast. J. Anim. Sci. 81, 1004-1012.
172. Van Vuuren, H. J. J., and Jacobs, C. J. (1992). Killer yeasts in the wine industry: a review. Am. J. Enol. Vitic. 43, 119-128.
173. Vandenplas, Y., Brunser, O., and Szajewska, H. (2009). Saccharomyces boulardii in childhood. Eur. J. Pediatr. 168, 253-265.
174. Viljoen, B. (2006). "Yeast ecological interactions. Yeast'yeast, yeast'bacteria, yeast'fungi interactions and yeasts as biocontrol agents," in Yeasts in Food and Beverages, eds. A. Querol and G. Fleet (Berlin: Springer), 83-110.
175. Viljoen, B. C. (2001). The interaction between yeasts and bacteria in dairy environments. Int. J. Food Microbiol. 69, 37-44.
176. Villarruel, G., Rubio, D. M., Lopez, F., Cintioni, J., Gurevech, R., Romero, G., et al. (2007). Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebocontrolled study. Acta Paediatr. 96, 538-541.
177. Walker, G. M., McLeod, A. H., and Hodgson, V. J. (1995). Interactions between killer yeasts and pathogenic fungi. FEMS Microbiol. Lett. 127, 213-222.
178. Webster, J., and Weber, R. (2007). Introduction to Fungi. Cambridge University Press. Available at: http://books.google.ca/books?id= HZLXFi-om-0C
179. Weiler, F., and Schmitt, M. J. (2003). Zygocin, a secreted antifungal toxin of the yeast Zygosaccharomyces bailii, and its effect on sensitive fungal cells. FEMS Yeast Res. 3, 69-76.
180. Whelan, K. (2007). Enteral-tubefeeding diarrhoea: manipulating the colonic microbiota with probiotics and prebiotics. Proc. Nutr. Soc. 66, 299-306.
181. White, J. H., Butler, A. R., and Stark, M. J. R. (1989). Kluyveromyces lactis toxin does not inhibit yeast adenylyl cyclase. Nature 341, 666-668.
182. Wickner, R. B. (1996). Double-stranded RNA viruses of Saccharomyces cerevisiae. Microbiol. Rev. 60, 250-265.
183. Wijsman, M. R., Van Dijken, J. P., Van Kleeff, B. H., and Scheffers, W. A. (1984). Inhibition of fermentation and growth in batch cultures of the yeast Brettanomyces intermedius upon a shift from aerobic to anaerobic conditions (Custers effect). AntonieVan Leeuwenhoek 50, 183-192.
184. Wyder, M., and Puhan, Z. (1999). Role of selected yeasts in cheese ripening: an evaluation in aseptic cheese curd slurries. Int. Dairy J. 9, 3-10.
185. Xie, N., Zhou, T., and Li, B. (2012). Kefir yeasts enhance probiotic potentials of Lactobacillus paracasei H9: the positive effects of coaggregation between the two strains. Food Res. Int. 45, 394-401.
186. Yoshiuchi, K., Watanabe, M., and Nishimura, A. (2000). Breeding of a non-urea producing sake yeast with killer character using a kar1-1; mutant as a killer donor. J. Ind. Microbiol. Biotechnol. 24, 203-209.
187. Young, T. W. (1981). The genetic manipulation of killer character into brewing yeast. J. Inst. Brew. 87, 292-295.
188. Young, T. W., and Yagiu, M. (1978). A comparison of the killer character in different yeasts and its classification. Antonie Van Leeuwenhoek 44, 59-77.
189. Zhang, A. W., Lee, B. D., Lee, S. K., Lee, K. W., An, G. H., Song, K. B., et al. (2005). Effects of yeast (Saccharomyces cerevisiae) cell components on growth performance, meat quality, and ileal mucosa development of broiler chicks. Poult. Sci. 84, 1015-1021.